|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
|
|---|---|---|---|---|
| Assets | ||||
| Current assets | ||||
| Cash and cash equivalents | ||||
| Short-term investments | ||||
| Other receivables | ||||
| Prepaid expenses and other current assets | ||||
| Total current assets | ||||
| Other non-current assets | ||||
| Property and equipment, net | ||||
| Deferred offering costs | ||||
| Right-of-use asset | ||||
| Total assets | ||||
| Liabilities, redeemable convertible preferred stock and stockholders' equity (deficit) | ||||
| Current liabilities | ||||
| Accounts payable | ||||
| Payroll-related accruals | ||||
| Other current liabilities | ||||
| Lease liability, current | ||||
| Redeemable convertible preferred stock tranche liability | ||||
| Total current liabilities | ||||
| Lease liability, non-current | ||||
| Total liabilities | ||||
| Redeemable convertible preferred stock, $.00001 par value; 0 shares authorized, issued and outstanding as of September 30, 2026; 116,618,581 shares authorized, 20,341,968 shares issued and outstanding as of December 31, 2025 (aggregate liquidation preference of $0 and $200,878 as of September 30, 2026 and December 31, 2025, respectively) | ||||
| Stockholders' equity (deficit) | ||||
| Preferred stock, $.00001 par value; 200,000,000 shares authorized, 0 shares issued and outstanding as of September 30, 2026; 0 shares authorized, issued, and outstanding as of December 31, 2025 | ||||
| Common stock, $.00001 par value; 1,000,000,000 shares authorized, 33,457,450 shares issued and outstanding as of September 30, 2026; 154,383,336 shares authorized; 2,203,620 shares issued and outstanding as of December 31, 2025 | ||||
| Common stock additional paid-in capital | ||||
| Accumulated deficit | ||||
| Total stockholders' equity (deficit) | ||||
| Total liabilities, redeemable convertible preferred stock and stockholders' equity (deficit) |
Loading...